Skip to main content
SpringerLink
Log in

Diagnostic Approaches to Hematopoietic Disorders of the Spleen and Liver

  • Chapter
  • First Online:
Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver

  • 924 Accesses

Abstract

The spleen is the largest lymphoid tissue in the human body and is composed of red and white pulp along with the supporting stroma. It is an important organ for filtration, immune regulation, and hematopoiesis during fetal development. Although the intact immune modulation from the spleen would protect human beings from diseases, there are a number of primary and secondary hematologic malignancies that may occur when immunity of the spleen is compromised or overridden by other processes. Additional non-hematopoietic diseases affecting the spleen include, but are not limited to, viral, bacterial, fungal, and parasitic infections, sarcoidosis, and storage disorders; these diseases may sometimes mimic primary hematologic neoplasms. The chapter will focus on conventional diagnostic approaches to hematologic disorders of the liver and spleen, mainly including gross and microscopic examination and immunophenotyping. Biopsy indications and histology processes have also been discussed.   

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606–16.

    Article  CAS  PubMed  Google Scholar 

  2. Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013;39(5):806–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Corless JK, Middleton HM 3rd. Normal liver function. A basis for understanding hepatic disease. Arch Intern Med. 1983;143(12):2291–4.

    Article  CAS  PubMed  Google Scholar 

  4. Torbenson M, Zen Y, Yeh M. Tumors of the liver. Washington, D.C.: ARP Press; 2018.

    Google Scholar 

  5. Hiatt J, Phillips E, Morgenstern L. Surgical diseases of the spleen. Heidelberg: Springer; 1997.

    Book  Google Scholar 

  6. Johnson HA, Deterling RA. Massive splenomegaly. Surg Gynecol Obstet. 1989;168(2):131–7.

    CAS  PubMed  Google Scholar 

  7. Lehne G, Hannisdal E, Langholm R, Nome O. A 10-year experience with splenectomy in patients with malignant non-Hodgkin’s lymphoma at the Norwegian Radium Hospital. Cancer. 1994;74(3):933–9.

    Article  CAS  PubMed  Google Scholar 

  8. Lv Y, Lau WY, Li Y, et al. Hypersplenism: history and current status. Exp Ther Med. 2016;12(4):2377–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cadili A, de Gara C. Complications of splenectomy. Am J Med. 2008;121(5):371–5.

    Article  PubMed  Google Scholar 

  10. Machado NO, Grant CS, Alkindi S, et al. Splenectomy for haematological disorders: a single center study in 150 patients from Oman. Int J Surg. 2009;7(5):476–81.

    Article  PubMed  Google Scholar 

  11. Dendle C, Sundararajan V, Spelman T, Jolley D, Woolley I. Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria. Med J Aust. 2012;196(9):582–6.

    Article  PubMed  Google Scholar 

  12. Alzen G, Basedow J, Luedemann M, Berthold LD, Zimmer KP. Partial splenic embolization as an alternative to splenectomy in hypersplenism–single center experience in 16 years. Klin Padiatr. 2010;222(6):368–73.

    Article  CAS  PubMed  Google Scholar 

  13. Amin MA, el-Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg. 2009;33(8):1702–10.

    Article  PubMed  Google Scholar 

  14. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(1):3–40.

    Article  CAS  PubMed  Google Scholar 

  15. Kappers-Klunne MC, Wijermans P, Fijnheer R, et al. Splenectomy for the treatment of thrombotic thrombocytopenic purpura. Br J Haematol. 2005;130(5):768–76.

    Article  CAS  PubMed  Google Scholar 

  16. Bonnet S, Guedon A, Ribeil JA, Suarez F, Tamburini J, Gaujoux S. Indications and outcome of splenectomy in hematologic disease. J Visc Surg. 2017;154(6):421–9.

    Article  CAS  PubMed  Google Scholar 

  17. Katz SC, Pachter HL. Indications for splenectomy. Am Surg. 2006;72(7):565–80.

    Article  PubMed  Google Scholar 

  18. Singh AK, Shankar S, Gervais DA, Hahn PF, Mueller PR. Image-guided percutaneous splenic interventions. Radiographics. 2012;32(2):523–34.

    Article  PubMed  Google Scholar 

  19. Patel N, Dawe G, Tung K. Ultrasound-guided percutaneous splenic biopsy using an 18-G core biopsy needle: our experience with 52 cases. Br J Radiol. 2015;88(1055):20150400.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Libepathology.org/wiki/splenectomy-grossing. In: Patholog L, ed 2019.

  21. Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics. 2004;24(4):1137–63.

    Article  PubMed  Google Scholar 

  22. O’Malley DP, George T, Orazi A, Abbondanzo S. Benign and reactive conditions of lymph node and spleen, vol. 7. Washington, D.C.: American Registery of Pathology; 2009.

    Google Scholar 

  23. Lester. Manual of surgical pathology. Philadelphia: Churchill Livingstone; 2001.

    Google Scholar 

  24. Wotherspoon A, Attygalle A, Mendes LS. Bone marrow and splenic histology in hairy cell leukaemia. Best Pract Res Clin Haematol. 2015;28(4):200–7.

    Article  PubMed  Google Scholar 

  25. Urrutia M, Mergo PJ, Ros LH, Torres GM, Ros PR. Cystic masses of the spleen: radiologic-pathologic correlation. Radiographics. 1996;16(1):107–29.

    Article  CAS  PubMed  Google Scholar 

  26. Morgenstern L. Nonparasitic splenic cysts: pathogenesis, classification, and treatment. J Am Coll Surg. 2002;194(3):306–14.

    Article  PubMed  Google Scholar 

  27. McInnes MD, Kielar AZ, Macdonald DB. Percutaneous image-guided biopsy of the spleen: systematic review and meta-analysis of the complication rate and diagnostic accuracy. Radiology. 2011;260(3):699–708.

    Article  PubMed  Google Scholar 

  28. Keogan MT, Freed KS, Paulson EK, Nelson RC, Dodd LG. Imaging-guided percutaneous biopsy of focal splenic lesions: update on safety and effectiveness. AJR Am J Roentgenol. 1999;172(4):933–7.

    Article  CAS  PubMed  Google Scholar 

  29. Civardi G, Vallisa D, Berte R, et al. Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low risk in a multicenter Italian study. Am J Hematol. 2001;67(2):93–9.

    Article  CAS  PubMed  Google Scholar 

  30. Tam A, Krishnamurthy S, Pillsbury EP, et al. Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases. J Vasc Interv Radiol. 2008;19(1):80–7.

    Article  PubMed  Google Scholar 

  31. Friedlander MA, Wei XJ, Iyengar P, Moreira AL. Diagnostic pitfalls in fine needle aspiration biopsy of the spleen. Diagn Cytopathol. 2008;36(2):69–75.

    Article  PubMed  Google Scholar 

  32. Ramdall RB, Cai G, Alasio TM, Levine P. Fine-needle aspiration biopsy for the primary diagnosis of lymphoproliferative disorders involving the spleen: one institution’s experience and review of the literature. Diagn Cytopathol. 2006;34(12):812–7.

    Article  PubMed  Google Scholar 

  33. Gomez-Rubio M, Lopez-Cano A, Rendon P, et al. Safety and diagnostic accuracy of percutaneous ultrasound-guided biopsy of the spleen: a multicenter study. J Clin Ultrasound. 2009;37(8):445–50.

    Article  PubMed  Google Scholar 

  34. Phillips EH, Carroll BJ, Fallas MJ. Laparoscopic splenectomy. Surg Endosc. 1994;8(8):931–3.

    Article  CAS  PubMed  Google Scholar 

  35. Poulin EC, Thibault C, Mamazza J. Laparoscopic splenectomy. Surg Endosc. 1995;9(2):172–6; discussion 176–7

    Article  CAS  PubMed  Google Scholar 

  36. Bonds LA, Barnes P, Foucar K, Sever CE. Acetic acid-zinc-formalin: a safe alternative to B-5 fixative. Am J Clin Pathol. 2005;124(2):205–11.

    Article  CAS  PubMed  Google Scholar 

  37. Medeiros L, O’Malley DP, Caraway N, Vega F, Elenitoba-Johnson K, Lim M. Tumors of the lymph nodes and spleen. Washington, D.C.: ARP Press. 2017

    Google Scholar 

  38. Neiman RS. Incidence and importance of splenic sarcoid-like granulomas. Arch Pathol Lab Med. 1977;101(10):518–21.

    CAS  PubMed  Google Scholar 

  39. Rosso R, Neiman RS, Paulli M, et al. Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. Hum Pathol. 1995;26(1):39–46.

    Article  CAS  PubMed  Google Scholar 

  40. Borch WR, Aguilera NS, Brissette MD, O'Malley DP, Auerbach A. Practical applications in immunohistochemistry: an immunophenotypic approach to the spleen. Arch Pathol Lab Med. 2019;143(9):1093–105.

    Article  CAS  PubMed  Google Scholar 

  41. Grimm K, Barry T, Omarrley D, Weiss L. Immunophenotypic markers useful in the diagnosis and classification of hematopoietic and lymphoid neoplasms. In: Knowles’ neoplasmitc hematopathology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 1992. p. 91–118.

    Google Scholar 

  42. Sherman MJ, Hanson CA, Hoyer JD. An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia. Am J Clin Pathol. 2011;136(3):390–9.

    Article  PubMed  Google Scholar 

  43. Neiman R, Orazi A. Hematopmathologic manifestation of lymphoproliferative and myeloproliferative disorders involving the spleen. In: DM K, editor. Neoplastic hematopathology. Baltimore: Lipplincott Williams & Wilkins; 2000.

    Google Scholar 

  44. Du J, Shen Q, Yin H, Zhou X, Wu B. Littoral cell angioma of the spleen: report of three cases and literature review. Int J Clin Exp Pathol. 2015;8(7):8516–20.

    PubMed  PubMed Central  Google Scholar 

  45. Peckova K, Michal M, Hadravsky L, et al. Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies. Histopathology. 2016;69(5):762–74.

    Article  PubMed  Google Scholar 

  46. Ujjani C, Cheson BD. The current status and future impact of targeted therapies in non-Hodgkin lymphoma. Expert Rev Hematol. 2013;6(2):191–202; quiz 203

    Article  CAS  PubMed  Google Scholar 

  47. Miliotou AN, Papadopoulou LC. CAR T-cell therapy: a new era in cancer immunotherapy. Curr Pharm Biotechnol. 2018;19(1):5–18.

    Article  PubMed  CAS  Google Scholar 

  48. Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol. 2000;24(7):1016–9.

    Article  CAS  PubMed  Google Scholar 

  49. Sharpe RW, Bethel KJ. Hairy cell leukemia: diagnostic pathology. Hematol Oncol Clin North Am. 2006;20(5):1023–49.

    Article  PubMed  Google Scholar 

  50. Foucar K, Catovsky D, et al. Hairy cell leukemia. In: Swedlow S, Harris N, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissue. Lyon: LARC; 2008. p. 188–90.

    Google Scholar 

  51. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364(24):2305–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Arcaini L, Zibellini S, Boveri E, et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood. 2012;119(1):188–91.

    Article  CAS  PubMed  Google Scholar 

  53. Xi L, Arons E, Navarro W, et al. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 2012;119(14):3330–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Thieblemont C, Davi F, Noguera ME, et al. Splenic marginal zone lymphoma: current knowledge and future directions. Oncology (Williston Park). 2012;26(2):194–202.

    Google Scholar 

  55. Matutes E, Morilla R, Owusu-Ankomah K, Houliham A, Meeus P, Catovsky D. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma. 1994;14(Suppl 1):57–61.

    PubMed  Google Scholar 

  56. Jones G, Parry-Jones N, Wilkins B, Else M, Catovsky D, British Committee for Standards in H. Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant∗. Br J Haematol. 2012;156(2):186–95.

    Article  CAS  PubMed  Google Scholar 

  57. Mason EF, Brown RD, Szeto DP, et al. Detection of activating MAP 2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant. Leuk Lymphoma. 2017;58(1):233–6.

    Article  PubMed  Google Scholar 

  58. Waterfall JJ, Arons E, Walker RL, et al. High prevalence of MAP 2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Genet. 2014;46(1):8–10.

    Article  CAS  PubMed  Google Scholar 

  59. Traverse-Glehen A, Baseggio L, Bauchu EC, et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? Blood. 2008;111(4):2253–60.

    Article  CAS  PubMed  Google Scholar 

  60. Mendes LS, Attygalle A, Matutes E, Wotherspoon A. Annexin A1 expression in a splenic diffuse red pulp small B-cell lymphoma: report of the first case. Histopathology. 2013;63(4):590–3.

    PubMed  Google Scholar 

  61. Curiel-Olmo S, Mondejar R, Almaraz C, et al. Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations. Blood. 2017;129(8):1042–5.

    Article  CAS  PubMed  Google Scholar 

  62. Colovai AI, Giatzikis C, Ho EK, et al. Flow cytometric analysis of normal and reactive spleen. Mod Pathol. 2004;17(8):918–27.

    Article  PubMed  Google Scholar 

  63. Imashuku S, Obayashi M, Hosoi G, et al. Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19+ B-cell depletion and therapeutic results. Br J Haematol. 2000;108(3):505–10.

    Article  CAS  PubMed  Google Scholar 

  64. Lucio P, Parreira A, van den Beemd MW, et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia. 1999;13(3):419–27.

    Article  CAS  PubMed  Google Scholar 

  65. Zeppa P, Anniciello A, Vetrani A, Palombini L. Fine needle aspiration biopsy of hepatic focal fatty change. A report of two cases. Acta Cytol. 2002;46(3):567–70.

    Article  PubMed  Google Scholar 

  66. Howlett DC, Drinkwater KJ, Lawrence D, Barter S, Nicholson T. Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy. Part I. Procedural aspects, diagnostic adequacy, and accuracy. Radiology. 2012;265(3):819–31.

    Article  PubMed  Google Scholar 

  67. Laribi K, Lemaire P, Sandrini J, Baugier de Materre A. Advances in the understanding and management of T-cell prolymphocytic leukemia. Oncotarget. 2017;8(61):104664–86.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Tannapfel A, Dienes HP, Lohse AW. The indications for liver biopsy. Dtsch Arztebl Int. 2012;109(27–28):477–83.

    PubMed  PubMed Central  Google Scholar 

  69. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut. 1999;45 Suppl 4:IV1–IV11.

    Google Scholar 

  70. Mastoraki A, Stefanou MI, Chatzoglou E, et al. Primary hepatic lymphoma: dilemmas in diagnostic approach and therapeutic management. Indian J Hematol Blood Transfus. 2014;30(3):150–4.

    Article  PubMed  Google Scholar 

  71. Elsayes KM, Menias CO, Willatt JM, Pandya A, Wiggins M, Platt J. Primary hepatic lymphoma: imaging findings. J Med Imaging Radiat Oncol. 2009;53(4):373–9.

    Article  CAS  PubMed  Google Scholar 

  72. Gota VS, Purandare NC, Gujral S, Shah S, Nair R, Rangarajan V. Positron emission tomography / computerized tomography evaluation of primary Hodgkin’s disease of liver. Indian J Cancer. 2009;46(3):237–9.

    Article  CAS  PubMed  Google Scholar 

  73. El-Sharkawi D, Ramsay A, Cwynarski K, et al. Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques. Leuk Lymphoma. 2011;52(11):2130–4.

    Article  PubMed  Google Scholar 

  74. Fu DA, Campbell-Thompson M. Periodic acid-Schiff staining with diastase. Methods Mol Biol. 2017;1639:145–9.

    Article  CAS  PubMed  Google Scholar 

  75. Agmon-Levin N, Berger I, Shtalrid M, Schlanger H, Sthoeger ZM. Primary hepatic lymphoma: a case report and review of the literature. Age Ageing. 2004;33(6):637–40.

    Article  PubMed  Google Scholar 

  76. Anthony PP, Sarsfield P, Clarke T. Primary lymphoma of the liver: clinical and pathological features of 10 patients. J Clin Pathol. 1990;43(12):1007–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Swerdlow S, Campo E, Harris N, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017.

    Google Scholar 

  78. Salmon JS, Thompson MA, Arildsen RC, Greer JP. Non-Hodgkin’s lymphoma involving the liver: clinical and therapeutic considerations. Clin Lymphoma Myeloma. 2006;6(4):273–80.

    Article  PubMed  Google Scholar 

  79. Zucca E, Gregorini A, Cavalli F. Management of non-Hodgkin lymphomas arising at extranodal sites. Ther Umsch. 2010;67(10):517–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

    Ling Zhang & Pukhraz Basra

  2. Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Serhan Alkan

Authors
  1. Ling Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pukhraz Basra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Serhan Alkan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ling Zhang .

Editor information

Editors and Affiliations

  1. Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA

    Ling Zhang

  2. Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA

    Haipeng Shao

  3. Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Serhan Alkan

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zhang, L., Basra, P., Alkan, S. (2020). Diagnostic Approaches to Hematopoietic Disorders of the Spleen and Liver. In: Zhang, L., Shao, H., Alkan, S. (eds) Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver. Springer, Cham. https://doi.org/10.1007/978-3-030-37708-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-37708-3_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-37707-6

  • Online ISBN: 978-3-030-37708-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation